Laparoscopy assisted total mesorectal excision for rectal cancer / 中华胃肠外科杂志
Chinese Journal of Gastrointestinal Surgery
;
(12): 141-143, 2005.
Artigo
em Chinês
| WPRIM
| ID: wpr-252450
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the feasibility of laparoscopy assisted total mesorectal excision (TME) for rectal cancer.</p><p><b>METHOD</b>From March 2000 to November 2003,67 patients with rectal cancer received laparoscopy assisted TME,in whom 45 cases received anterior resection (AR),and 22 cases received abdominal perineal resection (APR).</p><p><b>RESULTS</b>The operation was performed according to the rules of TME. The operative bleeding volume ranged from 10 to 50 ml. The operative time ranged from 2.5 to 5 hours without operative related death. Gastrointestinal decompression time ranged from 8 to 24 hours after operation. The time of intaking fluid food ranged from 24 to 48 hours after operation; the time of taking general activity ranged from 1 to 3 days after operation,and the defecating time ranged from 1 to 5 days after operation. The time of the hospital stay ranged from 7 to 10 days. All patients were followed up from 3 to 43 months except 3 patients. Two patients had local recurrence, including 1 patient died of local recurrence; 2 patients had liver metastases including 1 patient died of tumor metastasis but another was still alive. No metastasis and recurrence was found in 19 patients within follow - up time of one year.</p><p><b>CONCLUSION</b>The laparoscopy assisted TME is a feasible approach for rectal cancer if surgeons have experience in open operation of laparoscopy assisted TME and good managing skills.</p>
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Neoplasias Retais
/
Reto
/
Cirurgia Geral
/
Procedimentos Cirúrgicos do Sistema Digestório
/
Estudos de Viabilidade
/
Laparoscopia
/
Mesentério
/
Métodos
Limite:
Idoso
/
Aged80
/
Feminino
/
Humanos
Idioma:
Chinês
Revista:
Chinese Journal of Gastrointestinal Surgery
Ano de publicação:
2005
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS